Stock LYTIX LYTIX BIOPHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Lytix Biopharma

Equities

LYTIX

NO0010405780

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-05-24 EDT 		5-day change 1st Jan Change
6 NOK +13.21% Intraday chart for Lytix Biopharma +7.14% +23.46%
04-25 Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity CI
04-10 Lytix Biopharma to Raise Up to NOK55 Million via Share Offering MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
LYTIX BIOPHARMA
Other Biotechnology & Medical Research
+13.21%+7.14%+23.46%-37.17% - 22.74M
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. LYTIX Stock
  4. Charts Lytix Biopharma
  5. Comparison Chart